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Bioelectrical impedance vector analysis (BIVA) and phase angle (PA) have been shown previously to 
indicate relative nutritional status in patients. The aim of this study was to investigate the 
application of BIVA and PA assessments in a cohort of frail older hospital patients and compare these 
assessments with malnutrition risk screening by MUST (Malnutrition Universal Screening Tool), and 
the MNA-SF® (Mini-Nutritional Assessment-Short Form). 
Methods 
Sixty-nine patients (n = 44 men; n = 25 women; age 82.1 ± 7.6 y [range 62–96 y]; body mass index 
25.8 ± 5.4 kg/m2 [range 16.6–45.1 kg/m2]) were recruited from hospital wards specializing in the 
care of frail older individuals from the United Kingdom. Bioelectrical impedance assessment was 
performed at 50 khz frequency, BIVA was performed using raw impedance data, PA was calculated, 
and data were compared against reference population groups. Patients were categorized by 
malnutrition risk by MUST and MNA-SF. 
Results 
BIVA indicated that the men and women in the study were significantly different from reference 
population groups (P < 0.0001), with a noticeable reduced capacitive reactance (xC) component. The 
group mean PA was 4.6° ± 1.1° (2.4°–9.2°). The mean PA for men was 4.7° ± 1.3° (2.4°–9.2°), and for 
women it was 4.5° ± 0.7° (2.8–6.0°). Group PA correlated with MNA-SF score (P = 0.05). MUST 
categorized patients predominantly at low risk for malnutrition (80%); whereas MNA-SF was at risk 
(46%) and malnourished (45%). 
Conclusions 
The significant reduction in xC component and PA is consistent with other studies and is indicative of 
a reduced body cell mass and nutritional status with aging and illness. The general trend in MNA-SF 
scoring was more consistent with these patterns as a group; but requires clarification in larger 
cohorts. Future studies are necessary with an aim to improve and optimize care of frail older people. 
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Aging and frailty are associated with physiological and potentially pathological changes that may 
increase the risk for malnutrition, including a reduction in appetite and food intake, a decrease in 
body protein, body cell mass (BCM), and skeletal muscle mass (SMM) [1], [2], [3] and [4]. The frailty 
phenotype may increase risk for morbidity and mortality, and frail older people may suffer from a 
range of acute and chronic illness, and present with sarcopenic, cachectic, and wasting conditions 
[1], [4], [5] and [6]. Hence, the ability to accurately determine nutritional status in older people in 
hospitals and long-term care (LTC) facilities has high clinical importance and specific nutritional risk-
screening tools have been developed and endorsed [7]. Currently in the United Kingdom, the MUST 
(Malnutrition Universal Screening Tool) is the gold standard used routinely in hospitals and LTC 
facilities in the screening of malnutrition and is endorsed by the British Association of Parenteral and 
Enteral Nutrition [7] and [8]. The MNA (Mini-Nutritional Assessment) also has been validated for use 
in older populations [7], [9], [10] and [11]. 
Bioelectrical impedance assessment (BIA) is an established, noninvasive portable tool for assessing 
body composition, and has potential use in assessing nutritional and clinical status [12], [13] and 
[14]. One issue of concern, however, is that BIA predictive equations may cause significant errors in 
older people and in comorbid states (e.g., due to potential hydration abnormalities, body 
measurement differences, and other unknown effects); thus use of raw impedance data, that is, the 
bioelectrical impedance vector analysis (BIVA) method by Piccoli and Pastori has been suggested 
[12], [13], [14], [15] and [16]. The methodology is based on the concept that body impedance (Z) is 
made up of two components—resistance (R) and reactance capacitance (xC)—and that by 
normalizing R and xC for height (H) in meters, and plotting relevant bivariate vectors in a graphical 
format, useful comparisons can be made (e.g., compared with reference populations with specified 
ages, sex, body mass index [BMI] and disease) [15] and [16]. The R component relates predominantly 
to water content and hydrated tissues and, in the normal healthy state, a decreased R/H correlates 
with body size (i.e., greater amount of hydrated tissue mass), and in illness may relate to edema and 
high water content. Similarly, a very high R in illness may relate to dehydration and wasting. The xC 
component relates to the electrical capacitance or reactance effects of cellular tissues (i.e., cell 
membrane, etc). Therefore, a high xC relates to higher BCM/lean mass and a low xC relates to lower 
BCM/lean mass. A lowering of xC is consistent with normal aging. More recently, a specific BIVA 
method was developed with demonstrated accuracy by using body circumference measurements 
[17]. 
The BIA phase angle (PA) reflects the contributions between R and xC [calculated using the equation: 
PA (degrees) = arctan (Xc/R) × (180/π)]. It has been found to be associated with nutritional status 
and to have prognostic potential in different disease states and in older patients [14], [18], [19] and 
[20]. The usefulness of the clinical application of the BIVA and PA measurements in frail older people 
is yet to be realized and is at present unknown. Furthermore, at present there have been only a 
handful of studies performed globally and from the United Kingdom assessing the relationship 
between BIVA and PA in frail older people and the relationship with risk for malnutrition. 
Therefore, the aims of this study were to investigate the use of BIVA and PA in frail older hospital 
inpatients and compare the relationship to malnutrition screening by MUST and MNA-SF. 
Methods 
Participants and study design 
This cohort study was undertaken between September 2012 and May 2013. Patients who were able 
to provide written informed consent were recruited consecutively from admissions to two hospital 
wards in Lincoln, United Kingdom, specializing in care of frail older patients. Patients were diagnosed 
as being significantly frail and with a range of comorbities that included cardiovascular disease, 
chronic heart failure, chronic kidney disease, chronic obstructive pulmonary disorder, cancer, 
diabetes, arthritis, and dementia. Patients were treated with polypharmacy. Full ethical approval 
was obtained from NHS Leicester, East Midlands Research Ethics Committee before study 
commencement. Ethical guidelines were followed and informed consent sought from all patients. 
Exclusion criteria from the study were inability or unwillingness to give informed consent, patients 
nil by mouth or were tube fed. BIA measures were contraindicated in patients with defibrillation or 
cardiac pacemaker devices. The aim was to recruit 100 to 150 patients in line with other similar 
studies; however the exclusion criterion of ability to consent and designated study time restraints 
dictated the current number. 
Anthropometric measurements 
Height (m) and weight (kg) measurements were completed by clinical staff. In some cases height had 
to be estimated (e.g., height from demi-span). BMI was calculated in kg/m2. 
Bioelectrical impedance measurements 
BIA measurements were taken using a single-frequency (50 kHz) Maltron® 916 S, bioelectrical 
impedance analyzer (Maltron International Ltd., Rayleigh, Essex, UK). Measurements were taken 
using a standard hand-to-foot tetra-polar technique with participants in the supine position, in 
accordance with the manufacturer's guidelines. Raw impedance measurements of resistance, R and 
capacitance, xC in ohms and PA were recorded. The PA component was calculated using the 
equation: PA (degrees) = arctan (Xc/R) × (180/π). R and xC data was used for subsequent BIVA 
analysis according to previous studies [15] and [16]. Participants' R and xC were normalized for H 
and group mean data ±SD were calculated. Data for the male and female groups were inputted into 
BIVA software and compared with the reference healthy adult population using confidence ellipses. 
Additionally, BIVA was performed on different MNA-SF and MUST screening categories for men and 
women. 
Nutritional assessment: MUST tool and MNA-SF screening 
MUST and MNA-SF screening were undertaken by clinical staff according to instructions and scores 
recorded. Scores were converted into categories for nutritional status using MUST and MNA scoring 
criteria either low risk/normal (0 points MUST; 12–14 MNA-SF), medium risk/at risk (1 point MUST; 
8–11 MNA-SF) and high risk/malnourished (≥2 points MUST; 0–7 MNA-SF). 
Data analysis 
Data is presented as mean average measurements ± SD with a range (minimum–maximum) and 
(median) values. Data were grouped into whole-participant group, women and men, and where 
relevant into BMI and nutritional screening categories. Statistical analysis was performed using IBM 
SPSS Statistics, version 19 (New York, NY USA). t Tests, analysis of variance, and Pearson correlations 
were used for normally distributed data and Mann-Whitney U, Kruskal-Wallis, and Spearman 
correlations tests for nonparametric data. For BIVA bivariate group vector comparisons, the 
Hotelling's T2 test and Mahalanobis distances (D) between groups were analyzed. T2, F, P, D values 
are presented. A P value <0.05 was considered statistically significant. 
Results 
Participants 
Study participants were predominantly white (2 men were Asian-Indian). In all, there were 69 
participants (44 men and 25 women), with a mean age of 81.2 ± 7.4 y (age range: 62–96 y). Full 
participant details can be found in Table 1. 
Table 1.  
Participant characteristics with bioelectrical impedance values∗ 
Group (N = 69) 
Men (n = 44) 
Women (n = 25) 
Age (y) 
82.1 ± 7.6 (62–96) [83] 
81.2 ± 7.4 (62–92) [82] 
83.6 ± 7.8 (68–96) [85] 
Height (m) 
1.68 ± 0.10 (1.37–1.85) [1.68] 
1.72 ± 0.07 (1.57–1.85) [1.74] 
1.64 ± 0.10 (1.37–1.78) [1.62]† 
Weight (kg) 
73.2 ± 15.0 (42.8–101.6) [71.2] 
73.6 ± 15.1 (42.8–101) [73.5] 
72.5 ± 15.0 (49.8–101.6) [70.3] 
Body mass index (kg/m2) 
25.8 ± 5.4 (16.6–45.1) [25.6] 
24.7 ± 4.7 (16.7–35.3) [24.4] 
28.0 ± 5.9 (18.5–45.2) [28.0]‡ 
Resistance at 50 kHz/height (Ω/m) 
310.9 ± 67.3 (134.8–447.6) [310.1] 
296.3 ± 65.1 (134.8–429.0) [297.6] 
334.0 ± 67.7 (215.8–447.6) [335]‡ 
Reactance at 50 kHz/height (Ω/m) 
25.2 ± 8.0 (5.6–51.3) [25] 
24.5 ± 8.7 (5.6–51.3) [23.6] 
26.3 ± 6.8 (11.0–36.0) [27.3] 
Phase angle at 50 kHz (degrees) 
4.6 ± 1.1 (2.4–9.2) [4.5] 
4.7 ± 1.3 (2.4–9.2) [4.5] 
4.5 ± 0.7 (2.8–6.0) [4.5] 













8.1 ± 2.8 (2–14) [8] 
7.9 ± 2.7 (2–14) [8] 
8.4 ± 2.9 (2–14) [8] 













Mean values presented ± SD, range (minimum–maximum) and [median] for the entire group; 
individual groups of men and women. 
† 
Significantly different compared with men (P < 0.001). 
‡ 
Significantly different compared with men (P < 0.05). 
The mean BMI was significantly higher in women than in men (28 versus 24.7 kg/m2), as was R/H 
(334 versus 296 Ω/m). Furthermore, the proportion of women within low-risk malnutrition score 
categories was numerically higher than men. 
BIVA analysis 
Table 1 shows impedance values for patient groups normalized for height (R/H and xC/H values). 
Group vector and confidence ellipses are shown in Figure 1. Study group men (M1) and women (F1) 
are plotted along with reference groups (M2-6, F2-6). Details of reference groups can be found in 
Table 2. Statistical comparison of groups also can be found in Figure 1 with Hotelling's T2 test, F, P, 
and Mahalanobis distance, D. The M1 and F1 patients from the study were significantly different 
compared with M2-6 and F2-6 (P < 0.00001). Note also the difference between M1 and F1 was T2 = 
6.1, F = 3, P = 0.056 and D = 0.62. 
Fig. 1.  
BIA vectograph (R/H and xC/H) showing relative bivariate vector positioning and confidence ellipses 
for participant study groups male, M1 (n = 44) and female, F1 (n = 25). Reference male and female 
population vectors are plotted (M2–6; F2–6) and full statistical analysis of group comparisons 
performed and presented including Hotelling's T2 test, F and P values and Mahalanobis distance, D 
(see comparison tables in Fig.). Reference data set details are found in Table 2. 
Table 2.  
Reference data groups used in BIVA Comparisons∗ 
Group 






White males, 78 y, 28 kg/m2, USA, RJL Systems 
161 
276 ± 35.4 
28.9 ± 9.2 
[24] 
M3 
White males, 16–85 y,16–31 kg/m2 Italy, Akern-RJL Systems 
354 
298.6 ± 43.2 
30.8 ± 7.8 
[16] 
M4 
White males, 60–69 y, 19–25 kg/m2, USA, Valhalla 
230 
270.4 ± 32.5 
33.1 ± 5.3 
[25] 
M5 
White men, 60–69 y, 25–30 kg/m2, USA, Valhalla 
97 
304.5 ± 33.8 
37.2 ± 6.0 
[25] 
M6 
White men, 60–69 y, 30–35 kg/m2, USA, Valhalla 
111 
248.3 ± 26.8 
31.5 ± 5.1 
[25] 
F2 
White women, 78 y, 27 kg/m2, USA, RJL Systems 
294 
362.4 ± 45.6 
32.8 ± 8.1 
[24] 
F3 
White women, 16–85 y,16–31 kg/m2 Italy, Akern-RJL Systems 
372 
371.9 ± 49.0 
34.4 ± 7.7 
[16] 
F4 
White women, 60–69 y, 19–25 kg/m2, USA 
140 
406.1 ± 49.3 
45.0 ± 6.6 
[25] 
F5 
White women, 60–69 y, 25–30 kg/m2, USA, Valhalla 
159 
362.1 ± 38.1 
42.9 ± 6.9 
[25] 
F6 
White women, 60–69 y, 25–30 kg/m2, USA, Valhalla 
87 
337.3 ± 44.6 
39.6 ± 6.5 
[25] 
BIVA, bioelectrical impedance vector analysis; BMI, body mass index 
∗ 
Includes group details, number of participants (n), R/H (Ω/m), xC/H (Ω/m), and reference citations. 
Notes from BIVA guide—Valhalla BIA device used in M4–6 and F4–6 has higher impedance readings 
(R × 10 Ω and xC × 12 Ω). 
BIVA categorization by BMI in ages ≥70 y 
The group characteristics were examined further by categorization of the participants (3 males and 1 
female, 60-69 y were omitted from analyses) aged ≥70 by BMI groups: 18.5 to 24.9, 25 to 29.9, and 
≥30 kg/m2 (two men were omitted because BMI <18.5 kg/m2). Data can be seen in Supplementary 
Table 1 and Figure 1. Key points include a significant difference between women 18.5 to 24.9 versus 
25 to 29.9 and 18.5 to 24.9 and ≥30 kg/m2 (P = 0.02). There was a visible trend for a shift to the right 
along the R/H axis and upward on the xC/H with decreasing BMI. 
BIVA categorization by MNA-SF and MUST 
The whole-study population was categorized by the MNA-SF screening score and data can be seen in 
Supplementary Table 2 and Figure 2. BIVA showed a trend for a shift to the right along the R/H axis 
between at-risk and malnourished groups. The difference between groups was not significant but 
there was a trend toward significance in women (P = 0.07) (and also included a visible downward 
shift in xC/H). BIVA categorization for MUST was performed in men in the low- and high-risk groups 
(see Supplementary Table 3 and Fig. 3). There was a similar trend with a shift toward the right on the 
R/H axis, which was significant (P = 0.03); however, note the high-risk vector ellipse has a large 
overlapping area. It was not possible to analyze medium-risk men or any female group comparisons 
due to lack of patient numbers. 
Fig. 2.  
The relationship between individual patient phase angle (PA) and MNA-SF scores (N = 69; 25 women, 
open circles and 44 men, closed circles). Graph indicates a high proportion of individual patients 
found within the at-risk and malnourished MNA-SF categories (e.g., scores 5–11) with PA <5°. A PA 
region of ∼5°–7° was chosen as a suitable range that is potentially linked to better health and lower 
risk for poor outcomes in this age range (e.g., nutritional risk, poor functional status, mortality, etc.). 
Region was selected based on previous data [14], [18], [19], [20], [21], [22] and [23]. Very high PA for 
older persons (e.g., 7°–10°) also may indicate abnormalities and poor outcomes [20]. 
BIA phase angle 
PA values are shown in Table 1. There were no significant correlations between PA and BMI or age, 
for the group as a whole or when taken separately by sex; although there was a trend toward 
significance for age (P = 0.08) with the whole group and with women. Grouping by BMI in patients 
≥70 y, the mean PA (and median) values for men with BMI 18.5 to 24.9 kg/m2 was 4.7° [4.5]; BMI 25 
to 29.9 kg/m2 was 4.5° [4.5]; BMI ≥30 kg/m2 was 5.4° [4.6]. Mean PA (and median) values for 
women with BMI 18.5 to 24.9 kg/m2 was 4.0° [4.0]; BMI 25 to 29.9 kg/m2 was 5.0° [4.9]; and BMI 
≥30 kg/m2 was 4.5° [4.5] ( supplementary Table 1). Correlations were performed on all other 
impedance measurements and only PA significantly correlated with the MNA-SF 1 to 14 score (group 
PA: R = 0.29, P = 0.05; women: R = 0.7, P < 0.0001; and men: R = 0.053, P = 0.74), whereas 
impedance (Z), R, R/H, xC, and xC/H did not. Although no correlation was found for men, inspection 
of spread of data points in Figure 2 shows that there were observations of high PA measurements 
that have been found to potentially indicate abnormal status, as cited using data from a previous 
study [20], and may also potentially skew statistical correlation. Grouping by MNA-SF malnutrition 
scoring ( supplementary Table 2), PA for men was normal 4.7° [4.7] (n = 3); at risk 4.7° [4.5] (n = 22); 
and malnourished 4.7° [4.4] (n = 19). For women normal 5.1° [5.1] (n = 3); at risk 4.7° [4.7] (n = 10); 
and malnourished 4.1° [3.9] (n = 12). Full PA for patients categorizing by MUST scores were as 
follows: low risk 4.8 [4.5] (n = 32); medium risk 4.0 [4.2] (n = 4); and high risk 5.0 [4.7] (n = 8); for 
women low risk 4.5° [4.5] (n = 22); medium risk 5.1 (n = 1); and high risk: 3.9 [3.9] (n = 2). 
Discussion 
BIVA and PA assessments have been previously shown to have potential value in the assessment of 
nutritional and prognostic status in patients. This study aimed to investigate BIVA and PA 
assessment in a group of frail older hospital patients, compared with reference values and with 
malnutrition risk screening (by MUST and MNA-SF). This was considered especially important, as 





BIVA was performed in accordance with a previously derived method [15] and [16]. Comparing the 
male and female group data sets using confidence ellipses, and Mahalanobis distances from 
reference population groups, highly significant differences (P < 0.0001) were observed ( Fig. 1). The 
areas of the ellipses are large, however, potentially indicating variability in R and xC impedance 
components, and are overlapping for male and female groups. The reason for these observations are 
most likely due to the lower patient numbers and general variability in patients including age, BMI, 
hydration status, disease-specific factors, and possibly medications. The study groups were also 
categorized by BMI (18.5–24.9, 25–29.9, and ≥30 kg/m2, with two men omitted due to BMI <18.5) 
for patients ≥70 y (3 men and 1 women ages 60–69 y were omitted). These categories were chosen 
based on previous studies that have performed similar categorization (e.g., large studies have used 
the ≥70 age as a cut point [21] and [23]). BIVA showed a significant difference in two of the female 
groups (BMI 18.5–24.9 versus 25–29.9 kg/m2 and 18.5–24.9 versus ≥30 kg/m2; supplementary Table 
1 and Fig. 1). For both men and women, the visible observation is a relative shortening of the vector 
with increasing BMI. Furthermore, the most apparent observation from the overall group data 
compared with reference populations ( Fig. 1) was also a relative shortening of the vector length, 
with a noticeable lowering in the xC/H component. A relative decrease in the xC/H component is 
understood to indicate a decrease in soft tissue mass/BCM, whereas a change in the R/H component 
indicates alterations in hydration status [14], [15] and [16]. Data from healthy white men, ages 50 to 
80 y, and a BMI range from normal weight to obese [22] showed a relative reduction in xC/H and 
increase in R/H in aging, indicating reductions in BCM and fat-free mass (FFM). An increase in the 
R/H component indicates a reduction in hydration status and was also found in groups of healthy 
older people in an earlier study [26]. However, after correction for body size and circumferences, 
there was no longer any significant effect of age on R; however, the downward reduction in xC 
remained. Data from this study shows in particular that the group of frail older hospitalized patients 
have significantly reduced mean xC/H values (e.g., Table 1, ∼24–26 ohm/m for the groups), 
compared with ∼28 to 35 previously observed [22], although note the individual differences in 
groups in Supplementary Table 1. 
 
Separating the groups of data into MNA-SF malnutrition risk category, there was a trend toward 
significance (P = 0.07) for women and distinctly visible shifting toward the right (increasing R/H) with 
malnutrition categorization from at risk to malnourished ( Supplementary Fig. 2). There were no 
significant differences between the groups or by statistically comparing the individual R, R/H, xC, or 
xC/H variables. Age was numerically higher with a trend toward significance (P = 0.09) in the female 
malnourished group compared with the at-risk group. Other studies have found distinct differences 
in group comparisons by MNA categorization, with a shifting of the vector along the R/H axis and 
decrease in xC/H with increasing risk for malnutrition [27] and [28]. It should be noted that the 
variation in MNA scoring was perhaps not considerably widely spread for the patient group studied 
here, with only small numbers <5 and >11 ( Table 1 and Fig. 2); although with more study 
participants the distribution may have altered and possibly led to more significant variation. 
Separating by MUST scores, BIVA was only possible for the male low-versus high-risk groups due to 
low patient numbers ( Supplementary Fig. 3) A similar trend and shift to the right of the R/H axis was 
observed (P = 0.03). 
 
The analyses of the groups from this study are important as they suggest that despite the variability 
in age and BMI, many of the patients most likely have significantly reduced soft tissue masses (e.g., 
BCM.), which is consistent in aging and probably in frailty syndrome. However, distinct variability in 
the R/H component may indicate variability in the patient status, that is, some may have 
uncomplicated forms of undernutrition and loss of body mass (reduction in xC and increase in R/H); 
whereas other patients may have higher body mass/BMI, obesity, diabetes, and other chronic 
disease complications such as chronic heart failure, which may lead to a shortening of the vector and 
reduction in the R/H component (e.g., due to hyperhydration/edema). These possible alterations 
may be consistent here (e.g., note the normal-high BMI range of patients, especially women [Table 
1] and the shortening of the R/H component). These complicated body composition alterations in 
frailty also may be a basis behind the potential BMI paradox in groups of older adults [29]. There are 
still many aspects that require further investigation with regard to BIVA accuracy, and it is known 
that potentially more accurate methods including specific BIVA are currently being developed [17]. 
 
The PA measurement relates to the xC/H ratio (arc-tangent xC/R × 180°/π) and its clinical relevance 
has been well documented, and recently discussed in detail [14]. PA has been suggested to be a 
superior prognostic marker and an indicator of nutritional and functional status. In aging, PA reduces 
due to the characteristic drop in the xC component. The mean PA values were lower here (Table 1 
and Supplementary Table 1) than reference values for healthy white Swiss adults [21] (men ≥70 y, 
BMI 18.5–50 kg/m2, mean PA range 5.03°–5.50°; and women, ≥70 y, mean PA range 5.07°–5.27°); 
and lower than values for healthy white Italian men, 70 to 80 y (BMI 18.5 to ≥30 kg/m2, PA 5.8°–
6.0°) [22]. In an American population of healthy adults, reference PA values for those ≥70 y were 
6.19° ± 0.97° for men (BMI 25.6 ± 4.2 kg/m2), and 5.64° ± 1.02° for women (BMI 26 ± 6.4 kg/m2) 
[23]. It should be noted that the variation between PA reference measurements might be potentially 
due to differences in individual population groups and BIA analyzer differences [21], [22] and [23]. 
The mean/median PA values were lower in this study, which also might indicate the effects of 
disease and frailty (Table 1 and Supplementary Table 1). One study categorized older people by PA 
and MNA score (men [n = 77]: 5.2° ± 1.3° [malnourished] versus 5.7° ± 1.0° [normal]; and women [n 
= 93]: 5.0° ± 1.0° [malnourished] versus 5.4° ± 0.9° [normal]) [28]. Another study summarized a 
number of studies and range of disease conditions whereby specific PA cutoff points increased poor 
outcomes—tending to be between ∼4° to 6° (although noting there is generally high variability from 
study to study [14]. It has been shown that a lower PA is associated with nutritional risk and 
malnutrition in middle-aged adults at hospital admission [18]. And another recent study determined 
the best PA cutoffs for predicting nutritional risk using area under the receiver operating 
characteristic curve analysis comparing healthy adults with hospitalized patients (<5.0° in men and 
<4.6° in women) [19]. In data presented here, the men had a lower PA (mean 4.7°/median 4.5°), 
MNA-SF at risk: 4.7°/4.5° [n = 22], and malnourished 4.7°/4.4° [n = 19]), but also, in particular, four 
patients had very high PA values (7.55°–9.24°). A U-shaped distribution has also been observed in 
older patients whereby those at the lowest (<3.5°–4°) and highest (>6.4°) values had increased 
hospital mortality rates [20]. 
 
Further to the BIVA and PA data presented, there was an apparent discordant trend observed 
between the MUST and MNA categorization, which is consistent with other analyses previously 
performed [30]. It could be suggested from the BIA BIVA and PA assessment that a majority of 
patients are within categories of a higher risk for malnutrition, as the data may indicate reduced 
nutritional and functional status. The MUST scoring patterns do not seem to corroborate this data as 
a patient group, whereas the MNA-SF scoring appears to be more in to line; but this would require 
clarification in larger cohort numbers. Although beyond the scope of this article, this possible 
discordance may be a serious clinical issue as frail comorbid older patients at high nutritional risk 
may go unreported, since the MUST is the current gold standard for assessing malnutrition risk in 
the United Kingdom. Data from this study also supports the notion of possible increased 
malnutrition risk despite being within normal BMI ranges (BMI paradox in older people) [29]. 
Limitations of the study included study group size and participant grouping. Furthermore, there is a 
total lack of comparison data from the United Kingdom, and hence appropriate reference studies 
have been compared against an older European white population. Finally, cross-validation of 
bioelectrical impedance analyzers is another possible source of variability. 
Conclusion 
This study provides important BIVA and PA data from a frail older hospitalized patient group in the 
United Kingdom, indicating a high prevalence of reduced nutritional status consistent with at-risk 
and malnourished patient groups. Taken as a whole group, MNA-SF screening appeared more in line 
with BIA data, whereas MUST categorized patients predominantly at low risk; however there was no 
clear statistical significant differentiation in BIVA patterns between screening score categories. 
Further studies in larger cohort groups are clearly necessary as there are implications for care of frail 
older people. 
Acknowledgments 
The authors acknowledge the ward staff at Lincoln County Hospital during the study; and Professor 




L.P. Fried, C.M. Tangen, J. Walston, A.B. Newman, C. Hirsch, J. Gottdiener, et al. 
Frailty in older adults: evidence for a phenotype 
J Gerontol A Biol Sci Med Sci, 56 (2001), pp. M146–M156 
[2] 
J.E. Morley 
Anorexia of aging: physiologic and pathologic 
Am J Clin Nutr, 66 (1997), pp. 760–773 
[3] 
U.G. Kyle, L. Genton, D. Hans, L. Karsegard, D.O. Slosman, C. Pichard 
Age-related differences in fat-free mass, skeletal muscle, body cell mass and fat mass between 18 
and 94 y 
Eur J Clin Nutr, 55 (2001), pp. 663–672 
 [4] 
J.M. Bauer, C.C. Sieber 
Sarcopenia and frailty: a clinician’s controversial point of view 
Exp Gerontol, 43 (2008), pp. 674–678 
 [5] 
B.E.K. Klein, R. Klein, M.D. Knudtson, K.E. Lee 
Frailty, morbidity and survival 
Arch Gerontol Geriatr, 41 (2005), pp. 141–149 
[6] 
M. Muscaritoli, S.D. Anker, J. Argilés, Z. Aversa, J.M. Bauer, G. Biolo, et al. 
Consensus definition of sarcopenia, cachexia and precachexia: joint document elaborated by Special 
Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics.” 
Clin Nutr, 29 (2010), pp. 154–159 
[7] 
J. Kondrup, S.P. Allison, M. Elia, B. Vellas, M. Plauth 
ESPEN Guidelines for Nutritional Screening 2002 
Clin Nutr, 22 (2003), pp. 415–421 
[8] 
M. Elia 
Screening for malnutrition: a multidisciplinary responsibility, development and use of the 
Malnutrition Universal Screening Tool (‘MUST’) for adults 
BAPEN, Redditch, UK (2003) 
[9] 
B. Vellas, H. Villars, G. Abellan, M.E. Soto, Y. Rolland, Y. Guigoz, et al. 
Overview of the MNA—Its history and challenges 
J Nutr Health Aging, 10 (2006), pp. 456–463 
 [10] 
L.Z. Rubenstein, J.O. Harker, A. Salva, Y. Guigoz, B. Vellas 
Screening for undernutrition in geriatric practice: developing the short-form mini nutritional 
assessment (MNA-SF) 
J Geront, 56 A (2001), pp. M366–M377 
[11] 
C.C. Sieber 
Nutritional screening tools-how does the MNA compare? 
J Nutr Health Aging, 10 (2006), pp. 488–494 
[12] 
U.G. Kyle, D.E. Bosaeus, A.D. Lorenzo, P. Deurenberg, M. Elia, J.M. Gómez, et al. 
Bioelectrical impedance analysis—part I: review of principles and methods 
Clin Nutr, 23 (2004), pp. 1226–1243 
[13] 
U.G. Kyle, D.E. Bosaeus, A.D. Lorenzo, P. Deurenberg, M. Elia, J.M. Gómez, et al. 
ESPEN Guidelines. Bioelectrical impedance analysis—part II: utilization in clinical practice 
Clin Nutr, 23 (2004), pp. 1430–1453 
[14] 
K. Norman, N. Stobäus, M. Pirlich, A. Bosy-Westphal 
Bioelectrical impedance phase angle and impedance vector analysis—Clinical relevance and 
applicability of impedance parameters 
Clin Nutr, 31 (2012), pp. 854–861 
 [15] 
A. Piccoli, G. Pastori, BIVA software 
Department of Medical and Surgical Sciences 
University of Padova, Padova, Italy (2002) 
[16] 
A. Piccoli, S. Nigrelli, A. Caberlotto, S. Bottazzo, B. Rossi, L. Pillon, et al. 
Bivariate normal values of the bioelectrical impedance vector in adult and elderly populations 
Am J Clin Nutr, 61 (1995), pp. 269–270 
 [17] 
R. Buffa, B. Saragat, S. Cabras, A.C. Rinaldi, E. Marini 
Accuracy of specific BIVA for the assessment of body composition 
PLoS One, 8 (2013), p. e58533 
[18] 
U.G. Kyle, M. Genton, C. Pichard 
Low phase angle determined by bioelectrical impedance analysis is associated with malnutrition and 
nutritional risk at hospital admission 
Clin Nutr, 32 (2013), pp. 294–299 
 [19] 
U.G. Kyle, E.P. Soundar, L. Genton, C. Pichard 
Can phase angle determined by bioelectrical impedance analysis assess nutritional risk? A 
comparison between healthy and hospitalized subjects 
Clin Nutr, 31 (2012), pp. 875–881 
[20] 
R. Wirth, D. Volkert, A. Rösler, C.C. Sieber, J.M. Bauer 
Bioelectric impedance phase angle is associated with hospital mortality of geriatric patients 
Arch Gerontol Geriatr, 51 (2010), pp. 290–294 
[21] 
A. Bosy-Westphal, S. Danielzik, R.-P. Dörhöfer, W. Later, S. Wiese, M.J. Müller 
Phase angle from bioelectrical impedance analysis: population reference values by age, sex, and 
body mass index 
JPEN J Parenter Enteral Nutr, 30 (2006), p. 309 
 [22] 
B. Guida, R. Laccetti, C. Gerardi, R. Trio, N.R. Perrino, P. Strazzullo, et al. 
Bioelectrical impedance analysis and age-related differences of body composition in the elderly 
Nutr Metab Cardiovasc Dis, 17 (2007), pp. 175–180 
 [23] 
M.C. Barbarosa-Silva, A.J.D. Barros, J. Wang, et al. 
Bioelectrical impedance reference analysis: population reference values for phase angle by age and 
sex 
Am J Clin Nutr, 2 (2005), pp. 49–52 
[24] 
R. Roubenoff, R.N. Baumgartner, T.B. Harris, G.E. Dallal, M.T. Hannan, C.D. Economos, et al. 
Application of bioelectrical impedance analysis to elderly populations 
J Gerontol Med Sci, 52 A (1997), pp. M129–M136 
 [25] 
A. Piccoli, L. Pillon, F. Dumler 
Impedance vector distribution by sex, race, body mass index, and age in the United States: standard 
reference intervals as bivariate Z scores 
Nutrition, 18 (2002), pp. 153–167 
 [26] 
R. Buffa, G. Floris, E. Marini 
Migration of the bioelectrical impedance vector in healthy elderly subjects 
Nutrition, 19 (2003), pp. 917–921 
 [27] 
K. Norman, C. Smoliner, L. Valentini, H. Lochs, M. Pirlich 
Is bioelectrical impedance vector analysis of value in the elderly with malnutrition and impaired 
functionality? 
Nutrition, 23 (2007), pp. 564–569 
[28] 
R. Buffa, G. Floris, E. Marini 
Assessment of nutritional status in free-living elderly individuals by bioelectrical impedance vector 
analysis 
Nutrition, 25 (2009), pp. 3–5 
 [29] 
K. Mattila, M. Haavisto, S. Rajala 
Body mass index and mortality in the elderly 
Br Med J, 292 (1986), pp. 867–868 
 [30] 
A. Slee 
Estimating nutritional status in a small cohort of elderly care home residents using MUST, MNA and 
bioelectrical impedance phase angle and vector analysis 
J Aging Res Clin Practice, 2 (2013), pp. 65–70 
AS was the lead author and designated study chief investigator. DS was the designated clinical 
principal investigator. DB was a clinical co-investigator involved in data collection and critical input 
into both the study and manuscript preparation. The authors declare that there are no conflicts of 
interest. 
